Science Explorer Back to mapMap

Most cited papers in Cancer-related cognitive impairment studies

Cancer-related cognitive impairment studies

What are the most cited papers in Cancer-related cognitive impairment studies?

The most cited paper in Cancer-related cognitive impairment studies is "Mild Cognitive Impairment" (Ronald C. Petersen, Glenn E. Smith, Stephen C. Waring et al., 1999), with 9,076 citations. Next come "The Functional Assessment of Cancer Therapy scale: development and validation of the general measure." (6,104) and "Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable" (3,064).

Showing 50 of 100 papers. Every paper with more than 685 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Mild Cognitive Impairment Ronald C. Petersen, Glenn E. Smith, Stephen C. Waring et al. · Archives of Neurology Mar 1999 9,076
2 The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. David F Cella, David S. Tulsky, Geoffrey V. Gray et al. · Journal of Clinical Oncology Mar 1993 6,104
3 Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable Kristin L. Campbell, Kerri M. Winters‐Stone, Joachim Wiskemann et al. · Medicine & Science in Sports & Exercise Open access 17 Oct 2019 3,064
4 Interpreting the significance of changes in health-related quality-of-life scores. David Osoba, George Rodrigues, James D. Myles et al. · Journal of Clinical Oncology 1998 2,991
5 Cancer treatment and survivorship statistics, 2012 Rebecca L. Siegel, Carol E. Desantis, Katherine S. Virgo et al. · CA A Cancer Journal for Clinicians Open access 14 Jun 2012 2,959
6 Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup Clifford R. Jack, Jeffrey Scott Andrews, Thomas G. Beach et al. · Alzheimer s & Dementia Open access 27 Jun 2024 2,670
7 Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment Ethan Basch, Allison Mary Deal, Amylou Constance Dueck et al. · JAMA Open access 6 Jun 2017 2,373
8 Exercise builds brain health: key roles of growth factor cascades and inflammation Carl W. Cotman, Nicole C. Berchtold, Lori‐Ann Christie · Trends in Neurosciences Review Sep 2007 2,289
9 Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women Sally Ann Shumaker, Claudine Legault, Stephen R. Rapp et al. · JAMA 27 May 2003 2,199
10 Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. Marianne J. Brady, David F Cella, Fei Mo et al. · Journal of Clinical Oncology Mar 1997 1,779
11 Donanemab in Early Alzheimer’s Disease Mark A. Mintun, Albert Lo, Cynthia Duggan Evans et al. · New England Journal of Medicine Open access 13 Mar 2021 1,776
12 Cancer-related fatigue—mechanisms, risk factors, and treatments Julienne E. Bower · Nature Reviews Clinical Oncology ReviewOpen access 12 Aug 2014 1,665
13 Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond Michael Platten, Ellen A. A. Nollen, Ute F. Röhrig et al. · Nature Reviews Drug Discovery ReviewOpen access 13 Feb 2019 1,617
14 The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress Russell K. Portenoy, Howard T. Thaler, Alice B. Kornblith et al. · European Journal of Cancer 1994 1,597
15 Exercise Is Associated with Reduced Risk for Incident Dementia among Persons 65 Years of Age and Older Eric B. Larson, Li Wang, James David Bowen et al. · Annals of Internal Medicine 17 Jan 2006 1,488
16 Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment Clifford R. Jack, Ronald Petersen, Yun Xu et al. · Neurology Open access Apr 1999 1,418
17 Prevalence of Depression in Patients With Cancer Mary Jane Massie · JNCI Monographs Open access Jul 2004 1,417
18 Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts Thomas K. Karikari et al. · The Lancet Neurology Open access 22 Apr 2020 1,411
19 Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women Women's Health Initiative Memory Study Sally Ann Shumaker · JAMA 22 Jun 2004 1,370
20 An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis Rebecca M. Speck, Kerry S. Courneya, Louise C. Mâsse et al. · Journal of Cancer Survivorship Review 5 Jan 2010 1,361
21 Participation in Cognitively Stimulating Activities and Risk of Incident Alzheimer Disease Robert S. Wilson · JAMA 13 Feb 2002 1,344
22 Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition Gregory A. Curt, WILLIAM S. BREITBART, David F Cella et al. · The Oncologist Oct 2000 1,261
23 Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies Sébastien Simard, Belinda Thewes, Gerry M. Humphris et al. · Journal of Cancer Survivorship Review 9 Mar 2013 1,244
24 Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline Dawn L. Hershman, Christina Lacchetti, Robert H. Dworkin et al. · Journal of Clinical Oncology Open access 15 Apr 2014 1,233
25 Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tomé et al. · Journal of Clinical Oncology Open access 28 Oct 2014 1,160
26 Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score Martine Extermann, I. Boler, Richard R. Reich et al. · Cancer Open access 9 Nov 2011 1,159
27 Fatigue in Breast Cancer Survivors: Occurrence, Correlates, and Impact on Quality of Life Julienne E. Bower, Patricia A. Ganz, Katherine A. Desmond et al. · Journal of Clinical Oncology 14 Feb 2000 1,151
28 Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update Charles L. Loprinzi, Christina Lacchetti, Jonathan Scott Bleeker et al. · Journal of Clinical Oncology Open access 14 Jul 2020 1,132
29 Diurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival Sandra E. Sephton · JNCI Journal of the National Cancer Institute 21 Jun 2000 1,103
30 Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis Margaret L. McNeely · Canadian Medical Association Journal ReviewOpen access 4 Jul 2006 1,096
31 Exercise for the management of cancer-related fatigue in adults Fiona L. Cramp, James Byron‐Daniel · Cochrane Database of Systematic Reviews Open access 8 Nov 2012 1,093
32 Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies Tali Cukierman, Hertzel C. Gerstein, Jeff D. Williamson · Diabetologia 8 Nov 2005 1,062
33 Quality of Life in Long-Term, Disease-Free Survivors of Breast Cancer: a Follow-up Study Peter Ganz · JNCI Journal of the National Cancer Institute 2 Jan 2002 1,059
34 Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Amylou Constance Dueck et al. · JAMA Oncology Open access 13 Aug 2015 1,045
35 International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer Jeffrey Scott Wefel, Janette L. Vardy, Tim A. Ahles et al. · The Lancet Oncology 26 Feb 2011 1,022
36 The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease Kathryn A. Ellis, Ashley Ian Bush, David Darby et al. · International Psychogeriatrics Open access 27 May 2009 1,010
37 Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. Ruth A. Mulnard, Carl W. Cotman, Claudia H. Kawas et al. · PubMed Open access 23 Feb 2000 996
38 Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials Michael J Grundman · Archives of Neurology 2004 979
39 Anthracycline Chemotherapy and Cardiotoxicity John McGowan, Robin Chung, Angshuman Maulik et al. · Cardiovascular Drugs and Therapy Open access Feb 2017 972
40 A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease Claudia H. Kawas, Susan M. Resnick, Anthony D. Morrison et al. · Neurology Open access Jun 1997 970
41 Cancer-Related Fatigue, Version 2.2015 Ann M. Berger et al. · Journal of the National Comprehensive Cancer Network Open access Aug 2015 964
42 Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial Paul David Brown, Shannon K. Pugh, Nadia N. Laack et al. · Neuro-Oncology Open access 16 Aug 2013 963
43 Management of Cancer in the Older Person: A Practical Approach Lodovico Balducci, Martine Extermann · The Oncologist Jun 2000 955
44 Radiation‐induced dementia in patients cured of brain metastases Lisa Marie DeAngelis, Jean‐Yves Delattre, Jerome B. Posner · Neurology Jun 1989 951
45 Estrogen Therapy in Postmenopausal Women Kristine S. Yaffe, George F. Sawaya, Ivan M. Lieberburg et al. · JAMA 4 Mar 1998 949
46 High levels of untreated distress and fatigue in cancer patients Linda Ellen Carlson, Maureen Angen, Jodi Cullum et al. · British Journal of Cancer Open access 25 May 2004 948
47 Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women Stephen R. Rapp, Mark Andrew Espeland, Sally Ann Shumaker et al. · JAMA 27 May 2003 936
48 Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue Karen Michelle Mustian, Catherine M. Alfano, Charles E. Heckler et al. · JAMA Oncology Open access 2 Mar 2017 927
49 Candidate mechanisms for chemotherapy-induced cognitive changes Tim A. Ahles, Andrew J. Saykin · Nature reviews. Cancer ReviewOpen access 23 Feb 2007 925
50 Prevalence of depression in cancer patients: a meta‐analysis of diagnostic interviews and self‐report instruments A.M.H. Krebber, Laurien M. Buffart, Gitta Kleijn et al. · Psycho-Oncology Open access 16 Sep 2013 920

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.